William Blair downgrades Endava stock rating to Market Perform on challenging growth outlook

William Blair downgraded Endava PLC (DAVA) from Outperform to Market Perform, citing a more challenging growth recovery outlook and constrained demand, following a 76% share price decline over the past year. This downgrade coincides with the company's disappointing Q1 FY2026 financial results, which missed analyst expectations for both EPS ($0.15 vs. $0.18 forecast) and revenue (GBP 178.2 million vs. GBP 188.78 million anticipated). The firm anticipates Endava shares will remain under pressure due to ongoing growth challenges and a difficult business environment.

Analysis

William Blair downgraded Endava PLC (DAVA) from Outperform to Market Perform, citing a more challenging growth recovery outlook and constrained demand. This follows a significant 76% share price decline over the past year, with DAVA now trading at $6.95, just above its 52-week low of $6.64. The market reaction to recent news has been notably negative, aligning with a strongly negative sentiment score of -0.85.

The downgrade is underpinned by Endava's disappointing Q1 FY2026 financial results, where EPS of $0.15 missed analyst forecasts of $0.18, and revenue of GBP 178.2 million fell short of the anticipated GBP 188.78 million. William Blair noted the company's ongoing disappointing guidance, indicating a difficult business environment and a -16.67% negative surprise in EPS.

The firm anticipates DAVA shares will "remain in the penalty box near term" due to persistent growth challenges and a difficult business environment. While potential short-term relief from easing interest rates or improved tariff visibility could drive discretionary spending, the overall market conditions for Endava remain challenging, impacting near-term prospects.

Key Decisions for Investors

• Investors should re-evaluate their positions in DAVA given the significant downgrade, persistent growth challenges, and recent financial underperformance.
• It would be prudent to monitor upcoming guidance and any strategic responses from Endava, as the current market conditions suggest continued pressure.
• Consider the potential for further downside given the stock's proximity to its 52-week low and the analyst's pessimistic near-term outlook.